Equity
€777,584 ▲ 33.0%
M2 SURGERY has made a profit in every financial year since 2019.
M2 SURGERY
Lifetime
6 annual accounts with figures on one time axispeak €427,911 (2024)
€427,911▲ 23.8%
peak €218,612 (2023)
€196,119▼ 10.3%
peak €777,584 (2024)
€777,584▲ 33.0%
€726,086▼ 6.3%
Board2 names since 2019
2 directors and 1 other
Documentsfilings and deeds
30-09-202561 days late
2024micro format
Gross margin from €345,566 to €427,911Dividend €3,332Equity from €584,820 to €777,584Investments €95,909Cash from €305,925 to €397,738
Key points
from the 2024 annual accountsTurnover
≈ €660,000 estimated
The micro format states no turnover.
Investments
€111,491 2.7 × depreciation
Green is investment, beige is depreciation. Machinery stands 56.6% higher than in 2023.
Filings
6 annual accounts 107 days past the deadline
2025 accounts not filed: deadline was 31-07-2026.
Starting capital
€4,000 100 shares
Position in the sector
€777,584
More equity than 90% of companies in human health. Sector median €147,640 · 19,781 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 6,783 companies had the same profile as M2 SURGERY has now. Each dot stands for 17 companies, two years later.
96.7%
were still trading
2.7%
stopped another way
0.6%
went bankrupt
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 6,783 companies, not a prediction for M2 SURGERY. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 15-07-2019
Director, since 15-07-2019
- founderdeed of 17-07-2019
- founderdeed of 17-07-2019
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0730684370
Registered office moved from Forest to Rebecq
New registered office: rue d'Arenberg, 71 à 1430 Rebecq · Previous registered office: Chaussée d'Alsemberg 219 bte 604, 1190 Forest · General meeting of 01-06-2022 · Gazette deed
Incorporation
Founding capital of €4,000, 100 shares · Founders: and · Appointments: (director) and (director) · published on 17-07-2019 · Gazette deed
First establishment
Alsembergse Steenweg 219, Forest
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| M2 SURGERY Rebecq | €1.5m | €427,911 | 50.8% | - |
| JORQUERA SEBASTIAN Waterloo | €1.2m | €448,353 | 36.3% | - |
| Cabinet Médical Neptune Lasne | €1.9m | €471,565 | 4.7% | - |
| ALBiDENT Brasschaat | €1.7m | €431,424 | 34.2% | - |
| Dr. Frederik Kao Kalmthout | €1.8m | €439,322 | 60.7% | - |
| Docteur Stéphanie GASPARD, médecine générale Bastogne | €1.6m | €410,034 | 36.2% | - |
| Docteur Intissar Zahra Touati Anderlecht | €1.6m | €393,173 | 10.3% | - |
These companies have the same main activity as M2 SURGERY: general medical practice (NACE 86210). They are comparable in size and age: total assets between €1.2m and €1.9m, founded between 2017 and 2020.
Official details
Source: KBO- Status
- Active since 15-07-2019Normal situation
- Activity
- General medical practiceNACE 86210and 1 other
- Establishment unit
- 2.292.061.3021190 Forest, since 15-07-2019
- Financial year end
- 31 December
- Peppol
- Reachable since 03-12-2025
Insights on M2 SURGERY
M2 SURGERY files the micro format. That format states no turnover. The gross margin rose from €32,581 in 2019 to €427,911 in 2024.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.
Key facts about M2 SURGERY
- What is the company number of M2 SURGERY?
- The company number of M2 SURGERY is 0730.684.370. The VAT number is the same number with BE in front: BE 0730.684.370.
- Where is M2 SURGERY based?
- The registered office is at Rue Duc d'Arenberg 71, 1430 Rebecq.Company details
- What does M2 SURGERY do?
- According to the KBO register, the main activity is general medical practice (NACE 86210).
- What is the legal form of M2 SURGERY?
- M2 SURGERY is a private limited company (BV).
- When was M2 SURGERY founded?
- M2 SURGERY was founded on 15-07-2019.
- Is M2 SURGERY still active?
- Yes, M2 SURGERY is an active enterprise in the KBO register.
- What is the turnover of M2 SURGERY?
- The turnover in financial year 2024 is ≈ €660,000. This figure is estimated from the gross margin of €427,911 and 38 comparable companies (NACE 862). It probably lies between €570,000 and €820,000.Financials
- Is M2 SURGERY profitable?
- In financial year 2024, M2 SURGERY made a profit of €196,119.
- Where can I find the annual accounts of M2 SURGERY?
- M2 SURGERY filed 6 annual accounts with the National Bank of Belgium, the latest for financial year 2024.
Next steps
Work out how much credit to give this customer and on what payment terms.Credit check Check what to know before you do business with this company.Supplier due diligence Check whether you can accept this company as a client under the anti-money-laundering law.AML client file Check which of your other customers you can e-invoice via Peppol.Peppol check Compare this company with its sector.Sector benchmark See what changed in the latest annual accounts.What changed
See how customers, suppliers and banks see your own company and what to improve first.